◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksD › DOCM

DocMorris AG (DOCM) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Pharmaceutical Retailers · DATA UPDATED 2026-08-16

DocMorris AG (DOCM) operates in the Pharmaceutical Retailers industry and is headquartered in Frauenfeld, Switzerland with about 1,097 employees. Its market capitalization is roughly CHF 491 million. In the fiscal year ended 2024-12-31, DOCM reported CHF 1.0B in revenue and (CHF 97M) in net income.

DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. The company offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and first aid products.

Interactive charts & full statements →

DOCM Revenue & Earnings History — Annual Income Statement

Income statement2024-12-312023-12-312022-12-312021-12-31
Total RevenueCHF 1.0BCHF 970MCHF 931MCHF 1.7B
Gross ProfitCHF 216MCHF 203MCHF 160MCHF 260M
Operating Income (EBIT)(CHF 104M)(CHF 83M)(CHF 151M)(CHF 196M)
Net Income(CHF 97M)CHF 82M(CHF 171M)(CHF 226M)

CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DOCM Free Cash Flow History

DOCM Balance Sheet History

Balance sheet2024-12-312023-12-312022-12-312021-12-31
Total AssetsCHF 778MCHF 866MCHF 1.1BCHF 1.3B
Total LiabilitiesCHF 438MCHF 436MCHF 749MCHF 784M

CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DOCM viewer.

Other Companies in Pharmaceutical Retailers

← DOCAll “D” companiesDOCN →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.